Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin.

about

Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment.A safety evaluation of empagliflozin plus linagliptin for treating type 2 diabetes.Linagliptin inhibits lipopolysaccharide-induced inflammation in human U937 monocytes

P2860

Q45742313-86D8C174-BE6D-40B4-B86E-794D3485DB8E Q47766606-9C9113EB-C37C-40E3-A51D-B0C7E66FF13B Q57111484-A01A3940-7939-4F99-B79F-2F94067A3F03

P2860

Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin.

Item

http://www.wikidata.org/entity/Q38497122

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Management of patients with ty ...... rment: profile of linagliptin.

@en

type

Item

label

Management of patients with ty ...... rment: profile of linagliptin.

@en

prefLabel

Management of patients with ty ...... rment: profile of linagliptin.

@en

P1476

Management of patients with ty ...... rment: profile of linagliptin.

@en

P2093

Baptist Gallwitz

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Initial combination of linagliptin and metformin in patients with type 2 diabetes: efficacy and safety in a randomised, double-blind 1-year extension study.

Combination of linagliptin and metformin for the treatment of patients with type 2 diabetes.

Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus

P304

799-805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.S67076

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277080210

http://www.w3.org/2001/XMLSchema#string

P698

25999728

http://www.w3.org/2001/XMLSchema#string

P932

4437596

http://www.w3.org/2001/XMLSchema#string

Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin.

about

P2860

P2860

Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932